Oral HIV-1 Vaccine Technologies Using Optivax Copolymer

Newman, Mark J.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Small Business Innovation Research Grants (SBIR) - Phase I (R43)
• Project #: 1R43AI039276-01
• Application #: 2076371
• Study Section: Special Emphasis Panel (ZRG7-SSS-4 (02))
• Project Start: 1996-08-01
• Project End: 1997-07-31
• Budget Start: 1996-08-01
• Budget End: 1997-07-31
• Support Year: 1
• Fiscal Year: 1996

Institution

• Name: Vaxcel, Inc.
• City: Norcross
• State: GA
• Country: United States
• Zip Code: 30092